RSV vaccine candidate (lipid nanoparticle formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RSV vaccine candidate (lipid nanoparticle formulation), covering 2025-05-31 to 2025-05-31. Get the full timeline:
Most recent: Clinical Trial Update: Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older [Phase 1, Phase 2]